Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-07-31
1999-09-21
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3147
Patent
active
059554746
ABSTRACT:
This invention relates to the treatment of edematous conditions in an animal by administering a neurotensin antagonist having diuretic activity.
REFERENCES:
patent: 5204354 (1993-04-01), Chakravarty et al.
Dubuc et al., Br. J. Pharmacol., Jun. 1994, vol. 112, No. 2, 352-354.
Azzi et al., Eur. J. Pharmacol., Apr. 1, 1994, vol. 255, No. 1-3, 167-174.
Vink et al., Semin. Oncol., Sep. 1987, vol. 14, No. 3, 263-281.
Baranowska et al., Neuroendocrinol. Lett., 1987, vol. 9.
Kivlighn et al., Clin, Exp. Pharmacol. Physiol., Jun. 1990, vol. 17, No. 6, 401-412.
Rioux et al., Neuropeptides, Mar. 1985, vol. 6, No. 1, 1-12.
Jarvis William R. A.
Sanofi
LandOfFree
Use of neurotensin antagonists for the treatment of edematous co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of neurotensin antagonists for the treatment of edematous co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of neurotensin antagonists for the treatment of edematous co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80533